Funded Tech Companies
CytoDyn
Wondering who invested in CytoDyn? Yorkville Advisors invested in this biopharmaceutical company.
Company Overview
Company Name
CytoDyn
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1111 Main Street 660
Vancouver, WA 98660
USA
Vancouver, WA 98660
USA
Phone
Website
Email Address
Company Background Information
Overview
CytoDyn is committed to enhancing the lives of patients through target specific medicine. Our team is focused on developing leronlimab, a monoclonal antibody CCR5 receptor antagonist, as a platform drug with potential in a variety of indications in solid-tumor oncology.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/3/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jacob Lalezari
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs